结核与肺部疾病杂志 ›› 2026, Vol. 7 ›› Issue (1): 73-79.doi: 10.19983/j.issn.2096-8493.20250215

• 论著 • 上一篇    下一篇

DEGS2通过调控鞘脂代谢通路影响肺腺癌增殖凋亡及侵袭的研究

艾思远, 廉亮亮, 唐晓洋, 袁洪志()   

  1. 北京市房山区良乡医院胸心血管外科,北京 102000
  • 收稿日期:2026-01-09 出版日期:2026-02-20 发布日期:2026-02-09
  • 通信作者: 袁洪志,Email:LXxwk1234567@163.com

DEGS2 affects proliferation, apoptosis and invasion of lung adenocarcinoma by regulating sphingolipid metabolism pathway

Ai Siyuan, Lian Liangliang, Tang Xiaoyang, Yuan Hongzhi()   

  1. Department of Cardiothoracic Surgery, Liangxiang Hospital, Fangshan District, Beijing 102000, China
  • Received:2026-01-09 Online:2026-02-20 Published:2026-02-09
  • Contact: Yuan Hongzhi, Email: LXxwk1234567@163.com

摘要:

目的: 探究正常肺组织、肺腺癌癌旁和肺腺癌中所有基因的表达水平趋势,寻找特征性基因并进行实验验证。方法: 下载加州大学圣克鲁斯分校(University of California, Santa Cruz, UCSC)数据中心中癌症基因组图谱(the cancer genome atlas, TCGA)和基因型-组织表达项目(genotype-tissue expression, GTEX)的整合数据,采用R语言分析所有基因的表达趋势,寻找特征性基因,提取癌旁和肿瘤组织共同高表达的基因集,进行GO和KEGG分析富集情况,鉴定最显著的通路中在肺组织和癌旁及肺腺癌中变化最大的基因。通过细胞生物学实验验证候选基因在肿瘤中的作用。结果: 整合数据显示存在一群正常组织中低表达但在肺腺癌癌旁和肺腺癌中高表达的基因(DEGS2PIGYFUCAGM2A),GO分析显示该基因群富集最显著的通路是膜脂质代谢过程,对该通路基因和符合趋势的基因取交集,发现DEGS2在癌旁和癌组织中升高最明显,升高倍数达3.27倍。实验证实,敲除DEGS2 24h后细胞迁移能力下降,72h后细胞活性下降55.0%。结论: DEGS2在癌旁和肺腺癌中呈高表达,其表达能促进肺腺癌的增殖和迁移,从而进一步驱动从癌旁组织到癌的发展。

关键词: 肺腺癌, 鞘脂代谢, 细胞凋亡, 癌基因, DEGS2

Abstract:

Objective: To investigate the expression trends of all genes in normal lung tissues, paracancerous tissues and lung adenocarcinoma tissues, screen for characteristic genes and verify their functions via experiments. Methods: Integrated datasets of The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) were retrieved from the University of California, Santa Cruz (UCSC) Data Portal. R software was applied to analyze the expression trends of all genes, identify characteristic genes, and extract the gene set co-expressed at high levels in both paracancerous and tumor tissues. Subsequently, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed. Genes with the most significant expression alterations in the most enriched pathway were screened among normal lung tissues, paracancerous tissues and lung adenocarcinoma tissues. The role of candidate genes in tumorigenesis was validated using cell biology experiments. Results: Integrated data analysis identified a cluster of genes (DEGS2, PIGY, FUCA, GM2A) that were lowly expressed in normal tissues but highly expressed in both paracancerous and lung adenocarcinoma tissues. GO enrichment analysis demonstrated that these genes were most significantly enriched in the membrane lipid metabolic process pathway. Intersection analysis of genes involved in this pathway and those consistent with the aforementioned expression trend revealed that DEGS2 exhibited the most prominent upregulation in paracancerous and tumor tissues, with an upregulation fold change of 3.27 compared with normal tissues. Cell experiments confirmed that DEGS2 knockout led to a significant reduction in the migration ability of lung adenocarcinoma cells at 24 h post-transfection, and a 55.0% decrease in cell viability at 72 h post-transfection. Conclusion: DEGS2 is highly expressed in both paracancerous tissues and lung adenocarcinoma tissues. This elevated expression can promote the proliferation and migration of lung adenocarcinoma cells, thereby driving the progression from paracancerous tissues to malignant tumors.

Key words: Lung adenocarcinoma, Sphingolipids metabolism, Apoptosis, Oncogenes, DEGS2

中图分类号: